With 58962.0 shares changed hands, the volume of the stock remained lighter than its average volume of 2.93 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $1.6747 whereas the lowest price it dropped to was $1.5. The 52-week range on CHEK shows that it touched its highest point at $3.13 and its lowest point at $0.56 during that stretch. It currently has a 1-year price target of $7.00. Beta for the stock currently stands at 0.43.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CHEK was up-trending over the past week, with a rise of 11.03%, but this was up by 8.05% over a month. Three-month performance surged to 150.19% while six-month performance rose 96.82%. The stock gained 62.64% in the past year, while it has gained 95.84% so far this year.
Float and Shares Shorts:
At present, 5.85 million CHEK shares are outstanding with a float of 5.56 million shares on hand for trading. On 2025-11-14, short shares totaled 0.18 million, which was 310.0 higher than short shares on 1760486400. In addition to Mr. David Lontini as the firm’s Interim CEO & Chairman of the Board, Ms. Noa Reshef M.B.A. serves as its Head of Operations.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$2.51 being high and -$2.51 being low. For CHEK, this leads to a yearly average estimate of -$2.51. The surprise factor in the prior quarter was -$0.53.
